Stable Isotopes Labelled Compounds Comprehensive Study by Type (Carbon-13, Nitrogen-15, Oxygen-18, Deuterium, Other Isotopes), Application (Research {Biomedical Research, Pharmaceutical Research, Environmental & Ecological Research, Agricultural Research}, Clinical Diagnostics, Industrial, Other Applications), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals and Diagnostic Centers, Other End Users) Players and Region - Global Market Outlook to 2027

Stable Isotopes Labelled Compounds Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 2.93%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The Stable isotope labeling contains the usage of non-radioactive isotopes that can act as a tracer used to model several biochemical and chemical systems. The chosen isotope can act as a label on that compound that can be recognized through mass spectrometry (MS) and nuclear magnetic resonance (NMR). Some of the most common stable isotopes are 13C, 2H, and 15N, which can further be produced into NMR solvents, nucleic acids, amino acids, lipids, common metabolites, and cell growth media. According to AMA Research, the market for Stable Isotopes Labelled Compounds is expected to register a CAGR of 2.93% during the forecast period to 2027. This growth is primarily driven by Increase In R&D Activities In The Pharmaceutical And Biotechnology Sector .

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Historical Period2017-2021
UnitValue (USD Million)
Key Companies in StudyCambridge Isotope Laboratories, Inc. (United States), Merck KGaA (Germany), Urenco Limited (United Kingdom), Isosciences, LLC (An Mdp Chemicals Company) (United States), Medical Isotopes, Inc. (United States), Omicron Biochemicals, Inc. (United States), Nordion Inc. (A Sterigenics International LLC Company) (Canada), Trace Sciences International (Canada), Alsachim (France) and Taiyo Nippon Sanso Corporation (Japan)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Biotechnology sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Cambridge Isotope Laboratories, Inc. (United States), Merck KGaA (Germany), Urenco Limited (United Kingdom), Isosciences, LLC (An Mdp Chemicals Company) (United States), Medical Isotopes, Inc. (United States), Omicron Biochemicals, Inc. (United States), Nordion Inc. (A Sterigenics International LLC Company) (Canada), Trace Sciences International (Canada), Alsachim (France) and Taiyo Nippon Sanso Corporation (Japan) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:


Market Drivers
  • Increase In R&D Activities In The Pharmaceutical And Biotechnology Sector
  • Growing Proteomics Research
  • A Rising Prevalence Of Cancer
  • Favorable Regulatory scenario

Market Trend

Restraints
  • High Cost of Stable Isotope-Labeled Compounds

Opportunities
Rising Investments in Pharmaceutical R&D in Emerging Markets
Challenges
Dearth of Skilled Professionals

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Stable Isotopes Labelled Compounds Study Sheds Light on
— The Stable Isotopes Labelled Compounds Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Stable Isotopes Labelled Compounds industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Stable Isotopes Labelled Compounds industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Carbon-13
  • Nitrogen-15
  • Oxygen-18
  • Deuterium
  • Other Isotopes
By Application
  • Research {Biomedical Research, Pharmaceutical Research, Environmental & Ecological Research, Agricultural Research}
  • Clinical Diagnostics
  • Industrial
  • Other Applications
By End User
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals and Diagnostic Centers
  • Other End Users

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase In R&D Activities In The Pharmaceutical And Biotechnology Sector
      • 3.2.2. Growing Proteomics Research
      • 3.2.3. A Rising Prevalence Of Cancer
      • 3.2.4. Favorable Regulatory scenario
    • 3.3. Market Challenges
      • 3.3.1. Dearth of Skilled Professionals
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Stable Isotopes Labelled Compounds, by Type, Application, End User and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Stable Isotopes Labelled Compounds (Value)
      • 5.2.1. Global Stable Isotopes Labelled Compounds by: Type (Value)
        • 5.2.1.1. Carbon-13
        • 5.2.1.2. Nitrogen-15
        • 5.2.1.3. Oxygen-18
        • 5.2.1.4. Deuterium
        • 5.2.1.5. Other Isotopes
      • 5.2.2. Global Stable Isotopes Labelled Compounds by: Application (Value)
        • 5.2.2.1. Research {Biomedical Research, Pharmaceutical Research, Environmental & Ecological Research, Agricultural Research}
        • 5.2.2.2. Clinical Diagnostics
        • 5.2.2.3. Industrial
        • 5.2.2.4. Other Applications
      • 5.2.3. Global Stable Isotopes Labelled Compounds by: End User (Value)
        • 5.2.3.1. Pharmaceutical & Biotechnology Companies
        • 5.2.3.2. Academic & Research Institutes
        • 5.2.3.3. Hospitals and Diagnostic Centers
        • 5.2.3.4. Other End Users
      • 5.2.4. Global Stable Isotopes Labelled Compounds Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Stable Isotopes Labelled Compounds: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cambridge Isotope Laboratories, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck KGaA (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Urenco Limited (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Isosciences, LLC (An Mdp Chemicals Company) (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Medical Isotopes, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Omicron Biochemicals, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Nordion Inc. (A Sterigenics International LLC Company) (Canada)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Trace Sciences International (Canada)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Alsachim (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Taiyo Nippon Sanso Corporation (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Stable Isotopes Labelled Compounds Sale, by Type, Application, End User and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Stable Isotopes Labelled Compounds (Value)
      • 7.2.1. Global Stable Isotopes Labelled Compounds by: Type (Value)
        • 7.2.1.1. Carbon-13
        • 7.2.1.2. Nitrogen-15
        • 7.2.1.3. Oxygen-18
        • 7.2.1.4. Deuterium
        • 7.2.1.5. Other Isotopes
      • 7.2.2. Global Stable Isotopes Labelled Compounds by: Application (Value)
        • 7.2.2.1. Research {Biomedical Research, Pharmaceutical Research, Environmental & Ecological Research, Agricultural Research}
        • 7.2.2.2. Clinical Diagnostics
        • 7.2.2.3. Industrial
        • 7.2.2.4. Other Applications
      • 7.2.3. Global Stable Isotopes Labelled Compounds by: End User (Value)
        • 7.2.3.1. Pharmaceutical & Biotechnology Companies
        • 7.2.3.2. Academic & Research Institutes
        • 7.2.3.3. Hospitals and Diagnostic Centers
        • 7.2.3.4. Other End Users
      • 7.2.4. Global Stable Isotopes Labelled Compounds Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Stable Isotopes Labelled Compounds: by Type(USD Million)
  • Table 2. Stable Isotopes Labelled Compounds Carbon-13 , by Region USD Million (2016-2021)
  • Table 3. Stable Isotopes Labelled Compounds Nitrogen-15 , by Region USD Million (2016-2021)
  • Table 4. Stable Isotopes Labelled Compounds Oxygen-18 , by Region USD Million (2016-2021)
  • Table 5. Stable Isotopes Labelled Compounds Deuterium , by Region USD Million (2016-2021)
  • Table 6. Stable Isotopes Labelled Compounds Other Isotopes , by Region USD Million (2016-2021)
  • Table 7. Stable Isotopes Labelled Compounds: by Application(USD Million)
  • Table 8. Stable Isotopes Labelled Compounds Research {Biomedical Research, Pharmaceutical Research, Environmental & Ecological Research, Agricultural Research} , by Region USD Million (2016-2021)
  • Table 9. Stable Isotopes Labelled Compounds Clinical Diagnostics , by Region USD Million (2016-2021)
  • Table 10. Stable Isotopes Labelled Compounds Industrial , by Region USD Million (2016-2021)
  • Table 11. Stable Isotopes Labelled Compounds Other Applications , by Region USD Million (2016-2021)
  • Table 12. Stable Isotopes Labelled Compounds: by End User(USD Million)
  • Table 13. Stable Isotopes Labelled Compounds Pharmaceutical & Biotechnology Companies , by Region USD Million (2016-2021)
  • Table 14. Stable Isotopes Labelled Compounds Academic & Research Institutes , by Region USD Million (2016-2021)
  • Table 15. Stable Isotopes Labelled Compounds Hospitals and Diagnostic Centers , by Region USD Million (2016-2021)
  • Table 16. Stable Isotopes Labelled Compounds Other End Users , by Region USD Million (2016-2021)
  • Table 17. South America Stable Isotopes Labelled Compounds, by Country USD Million (2016-2021)
  • Table 18. South America Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 19. South America Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 20. South America Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 21. Brazil Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 22. Brazil Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 23. Brazil Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 24. Argentina Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 25. Argentina Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 26. Argentina Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 27. Rest of South America Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 28. Rest of South America Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 29. Rest of South America Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 30. Asia Pacific Stable Isotopes Labelled Compounds, by Country USD Million (2016-2021)
  • Table 31. Asia Pacific Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 32. Asia Pacific Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 33. Asia Pacific Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 34. China Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 35. China Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 36. China Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 37. Japan Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 38. Japan Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 39. Japan Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 40. India Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 41. India Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 42. India Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 43. South Korea Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 44. South Korea Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 45. South Korea Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 46. Taiwan Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 47. Taiwan Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 48. Taiwan Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 49. Australia Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 50. Australia Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 51. Australia Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 52. Rest of Asia-Pacific Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 53. Rest of Asia-Pacific Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 54. Rest of Asia-Pacific Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 55. Europe Stable Isotopes Labelled Compounds, by Country USD Million (2016-2021)
  • Table 56. Europe Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 57. Europe Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 58. Europe Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 59. Germany Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 60. Germany Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 61. Germany Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 62. France Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 63. France Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 64. France Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 65. Italy Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 66. Italy Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 67. Italy Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 68. United Kingdom Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 69. United Kingdom Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 70. United Kingdom Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 71. Netherlands Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 72. Netherlands Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 73. Netherlands Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 74. Rest of Europe Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 75. Rest of Europe Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 76. Rest of Europe Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 77. MEA Stable Isotopes Labelled Compounds, by Country USD Million (2016-2021)
  • Table 78. MEA Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 79. MEA Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 80. MEA Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 81. Middle East Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 82. Middle East Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 83. Middle East Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 84. Africa Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 85. Africa Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 86. Africa Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 87. North America Stable Isotopes Labelled Compounds, by Country USD Million (2016-2021)
  • Table 88. North America Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 89. North America Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 90. North America Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 91. United States Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 92. United States Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 93. United States Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 94. Canada Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 95. Canada Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 96. Canada Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 97. Mexico Stable Isotopes Labelled Compounds, by Type USD Million (2016-2021)
  • Table 98. Mexico Stable Isotopes Labelled Compounds, by Application USD Million (2016-2021)
  • Table 99. Mexico Stable Isotopes Labelled Compounds, by End User USD Million (2016-2021)
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Stable Isotopes Labelled Compounds: by Type(USD Million)
  • Table 111. Stable Isotopes Labelled Compounds Carbon-13 , by Region USD Million (2022-2027)
  • Table 112. Stable Isotopes Labelled Compounds Nitrogen-15 , by Region USD Million (2022-2027)
  • Table 113. Stable Isotopes Labelled Compounds Oxygen-18 , by Region USD Million (2022-2027)
  • Table 114. Stable Isotopes Labelled Compounds Deuterium , by Region USD Million (2022-2027)
  • Table 115. Stable Isotopes Labelled Compounds Other Isotopes , by Region USD Million (2022-2027)
  • Table 116. Stable Isotopes Labelled Compounds: by Application(USD Million)
  • Table 117. Stable Isotopes Labelled Compounds Research {Biomedical Research, Pharmaceutical Research, Environmental & Ecological Research, Agricultural Research} , by Region USD Million (2022-2027)
  • Table 118. Stable Isotopes Labelled Compounds Clinical Diagnostics , by Region USD Million (2022-2027)
  • Table 119. Stable Isotopes Labelled Compounds Industrial , by Region USD Million (2022-2027)
  • Table 120. Stable Isotopes Labelled Compounds Other Applications , by Region USD Million (2022-2027)
  • Table 121. Stable Isotopes Labelled Compounds: by End User(USD Million)
  • Table 122. Stable Isotopes Labelled Compounds Pharmaceutical & Biotechnology Companies , by Region USD Million (2022-2027)
  • Table 123. Stable Isotopes Labelled Compounds Academic & Research Institutes , by Region USD Million (2022-2027)
  • Table 124. Stable Isotopes Labelled Compounds Hospitals and Diagnostic Centers , by Region USD Million (2022-2027)
  • Table 125. Stable Isotopes Labelled Compounds Other End Users , by Region USD Million (2022-2027)
  • Table 126. South America Stable Isotopes Labelled Compounds, by Country USD Million (2022-2027)
  • Table 127. South America Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 128. South America Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 129. South America Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 130. Brazil Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 131. Brazil Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 132. Brazil Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 133. Argentina Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 134. Argentina Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 135. Argentina Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 136. Rest of South America Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 137. Rest of South America Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 138. Rest of South America Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 139. Asia Pacific Stable Isotopes Labelled Compounds, by Country USD Million (2022-2027)
  • Table 140. Asia Pacific Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 141. Asia Pacific Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 142. Asia Pacific Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 143. China Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 144. China Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 145. China Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 146. Japan Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 147. Japan Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 148. Japan Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 149. India Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 150. India Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 151. India Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 152. South Korea Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 153. South Korea Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 154. South Korea Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 155. Taiwan Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 156. Taiwan Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 157. Taiwan Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 158. Australia Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 159. Australia Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 160. Australia Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 161. Rest of Asia-Pacific Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 162. Rest of Asia-Pacific Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 163. Rest of Asia-Pacific Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 164. Europe Stable Isotopes Labelled Compounds, by Country USD Million (2022-2027)
  • Table 165. Europe Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 166. Europe Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 167. Europe Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 168. Germany Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 169. Germany Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 170. Germany Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 171. France Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 172. France Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 173. France Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 174. Italy Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 175. Italy Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 176. Italy Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 177. United Kingdom Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 178. United Kingdom Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 179. United Kingdom Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 180. Netherlands Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 181. Netherlands Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 182. Netherlands Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 183. Rest of Europe Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 184. Rest of Europe Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 185. Rest of Europe Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 186. MEA Stable Isotopes Labelled Compounds, by Country USD Million (2022-2027)
  • Table 187. MEA Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 188. MEA Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 189. MEA Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 190. Middle East Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 191. Middle East Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 192. Middle East Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 193. Africa Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 194. Africa Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 195. Africa Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 196. North America Stable Isotopes Labelled Compounds, by Country USD Million (2022-2027)
  • Table 197. North America Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 198. North America Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 199. North America Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 200. United States Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 201. United States Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 202. United States Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 203. Canada Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 204. Canada Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 205. Canada Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 206. Mexico Stable Isotopes Labelled Compounds, by Type USD Million (2022-2027)
  • Table 207. Mexico Stable Isotopes Labelled Compounds, by Application USD Million (2022-2027)
  • Table 208. Mexico Stable Isotopes Labelled Compounds, by End User USD Million (2022-2027)
  • Table 209. Research Programs/Design for This Report
  • Table 210. Key Data Information from Secondary Sources
  • Table 211. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Stable Isotopes Labelled Compounds: by Type USD Million (2016-2021)
  • Figure 5. Global Stable Isotopes Labelled Compounds: by Application USD Million (2016-2021)
  • Figure 6. Global Stable Isotopes Labelled Compounds: by End User USD Million (2016-2021)
  • Figure 7. South America Stable Isotopes Labelled Compounds Share (%), by Country
  • Figure 8. Asia Pacific Stable Isotopes Labelled Compounds Share (%), by Country
  • Figure 9. Europe Stable Isotopes Labelled Compounds Share (%), by Country
  • Figure 10. MEA Stable Isotopes Labelled Compounds Share (%), by Country
  • Figure 11. North America Stable Isotopes Labelled Compounds Share (%), by Country
  • Figure 12. Global Stable Isotopes Labelled Compounds share by Players 2021 (%)
  • Figure 13. Global Stable Isotopes Labelled Compounds share by Players (Top 3) 2021(%)
  • Figure 14. Global Stable Isotopes Labelled Compounds share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Cambridge Isotope Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Cambridge Isotope Laboratories, Inc. (United States) Revenue: by Geography 2021
  • Figure 18. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 19. Merck KGaA (Germany) Revenue: by Geography 2021
  • Figure 20. Urenco Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 21. Urenco Limited (United Kingdom) Revenue: by Geography 2021
  • Figure 22. Isosciences, LLC (An Mdp Chemicals Company) (United States) Revenue, Net Income and Gross profit
  • Figure 23. Isosciences, LLC (An Mdp Chemicals Company) (United States) Revenue: by Geography 2021
  • Figure 24. Medical Isotopes, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Medical Isotopes, Inc. (United States) Revenue: by Geography 2021
  • Figure 26. Omicron Biochemicals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Omicron Biochemicals, Inc. (United States) Revenue: by Geography 2021
  • Figure 28. Nordion Inc. (A Sterigenics International LLC Company) (Canada) Revenue, Net Income and Gross profit
  • Figure 29. Nordion Inc. (A Sterigenics International LLC Company) (Canada) Revenue: by Geography 2021
  • Figure 30. Trace Sciences International (Canada) Revenue, Net Income and Gross profit
  • Figure 31. Trace Sciences International (Canada) Revenue: by Geography 2021
  • Figure 32. Alsachim (France) Revenue, Net Income and Gross profit
  • Figure 33. Alsachim (France) Revenue: by Geography 2021
  • Figure 34. Taiyo Nippon Sanso Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 35. Taiyo Nippon Sanso Corporation (Japan) Revenue: by Geography 2021
  • Figure 36. Global Stable Isotopes Labelled Compounds: by Type USD Million (2022-2027)
  • Figure 37. Global Stable Isotopes Labelled Compounds: by Application USD Million (2022-2027)
  • Figure 38. Global Stable Isotopes Labelled Compounds: by End User USD Million (2022-2027)
  • Figure 39. South America Stable Isotopes Labelled Compounds Share (%), by Country
  • Figure 40. Asia Pacific Stable Isotopes Labelled Compounds Share (%), by Country
  • Figure 41. Europe Stable Isotopes Labelled Compounds Share (%), by Country
  • Figure 42. MEA Stable Isotopes Labelled Compounds Share (%), by Country
  • Figure 43. North America Stable Isotopes Labelled Compounds Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Cambridge Isotope Laboratories, Inc. (United States)
  • Merck KGaA (Germany)
  • Urenco Limited (United Kingdom)
  • Isosciences, LLC (An Mdp Chemicals Company) (United States)
  • Medical Isotopes, Inc. (United States)
  • Omicron Biochemicals, Inc. (United States)
  • Nordion Inc. (A Sterigenics International LLC Company) (Canada)
  • Trace Sciences International (Canada)
  • Alsachim (France)
  • Taiyo Nippon Sanso Corporation (Japan)
Additional players considered in the study are as follows:
Perkinelmer Inc. (United States) , Rotem Industries Israel Ltd (Israel)
Select User Access Type

Key Highlights of Report


Jun 2022 169 Pages 92 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2017-2021; Base year: 2021; Forecast period: 2022 to 2027
Companies that are profiled in Global Stable Isotopes Labelled Compounds Market are Cambridge Isotope Laboratories, Inc. (United States), Merck KGaA (Germany), Urenco Limited (United Kingdom), Isosciences, LLC (An Mdp Chemicals Company) (United States), Medical Isotopes, Inc. (United States), Omicron Biochemicals, Inc. (United States), Nordion Inc. (A Sterigenics International LLC Company) (Canada), Trace Sciences International (Canada), Alsachim (France) and Taiyo Nippon Sanso Corporation (Japan) etc.
Research {Biomedical Research, Pharmaceutical Research, Environmental & Ecological Research, Agricultural Research} segment in Global market to hold robust market share owing to "Increase In R&D Activities In The Pharmaceutical And Biotechnology Sector ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Stable Isotopes Labelled Compounds market throughout the forecasted period.

Know More About Global Stable Isotopes Labelled Compounds Market Report?